Clinical Trial Update: Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting [NA]

View source ↗

Summary

The clinical investigation evaluating the ABLE Exoskeleton's safety and performance in individuals with Multiple Sclerosis has completed. This update reports on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• ABLE Exoskeleton

Snippet

Sponsor: ABLE Human Motion S.L. | Conditions: Multiple Sclerosis | NA | Status: COMPLETED